9 May 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice on eight new medicines.

Two of the medicines accepted, pembrolizumab (Keytruda) and nivolumab (Opdivo), are for the treatment of oesophageal cancer.

Read SMC press release